Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Current State of the Development of Therapies for Emergency Prophylaxis and Treatment of Ebola Virus Disease

Nowadays vaccination of the population living in the endemic regions and widespread implementation of the potent therapies for the emergency prophylaxis and treatment into the clinical practice are regarded as the basic efficient and cost-effective measures for Ebola epidemic spread control. Objecti...

Full description

Bibliographic Details
Main Authors:	A. A. Petrov, V. N. Lebedev, T. M. Plekhanova, L. F. Stovba, G. V. Borisevich, O. N. Sidorova, O. V. Chukhralya, S. V. Borisevich
Format:	Article
Language:	Russian
Published:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2015-09-01
Series:	Проблемы особо опасных инфекций
Subjects:	вирус эбола лекарственные средства экстренная профилактика и лечение вирусспецифические антитела моноклональные антитела малые интерферирующие рнк антисмысловые фосфордиамидатные морфолиновые олигомеры ebola virus hemorrhagic fever medical products emergency prophylaxis and treatment virus-specific antibodies monoclonal antibodies small interfering rna anti-sense phosphordiamidate morpholine oligomers
Online Access:	https://journal.microbe.ru/jour/article/view/254

Similar Items

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
by: E. I. Kazachinskaya, et al.
Published: (2015-09-01)

“CAMEL” ANTIBODIES: FEATURES OF THEIR STRUCTURE, PREPARATION AND APPLICATION
by: Alexey Alekseevich Andreev, et al.
Published: (2020-06-01)

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases
by: A. A. Petrov, et al.
Published: (2020-05-01)

New Monoclonal Antibodies for the Diagnosis of Influenza and other Acute Respiratory Viral Infections
by: A. A. Sominina, et al.
Published: (2015-10-01)

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
by: A. V. Philippova, et al.
Published: (2019-10-01)

Preparations of next generation monoclonal antibodies (issues and prospects)
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

SMALL NONCODING RNA AS PERSPECTIVE BIOMARKERS: BIOGENESIS AND THERAPEUTIC STRATIGIES
by: V. V. Tiguntsev, et al.
Published: (2016-06-01)

Obtainment of Monoclonal Antibodies and Prospects of Their Application as Basis for Immunodiagnostic Aids for Crimean-Congo Hemorrhagic Fever Virus Detection
by: N. P. Khrapova, et al.
Published: (2015-03-01)

Safety issues of monoclonal antibodies used in rheumatology
by: A. V. Philippova, et al.
Published: (2020-01-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
by: A. A. Petrov, et al.
Published: (2015-09-01)

Manufacturing of Hybridomas-Producers of Monoclonal Anti-Bodies to Tularemia Agent Antigens
by: O. O. Fomenkov, et al.
Published: (2015-06-01)

Study of protectivity and antigenicity of vaccine based on ' cultural Asia-1 No.2145/ Tajikistan/2011 FMD Virus
by: D. A. Lozovoy, et al.
Published: (2018-04-01)

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection
by: N. E. Tereshkina, et al.
Published: (2013-06-01)

SEROPREVALENCE OF INFECTIOUS BURSAL DISEASE VIRUS IN PRIVATE POULTRY BREEDINGS OF UKRAINE FROM 2014 TO 2016
by: А. С. Пастиря, et al.
Published: (2017-06-01)

Utilization of Immunoblotting in Studies of Epitope Targeting in Monoclonal Antibodies to Melioidosis Agent Antigen 200 kDa
by: I. I. Korsakova, et al.
Published: (2014-12-01)

Current State of the Development of Next-Generation Vaccines against Ebola Virus Disease
by: T. E. Sizikova, et al.
Published: (2015-09-01)

Diagnosis of hepatitis c today and interpretation of infection markers
by: T. V. Kozhanova
Published: (2013-12-01)

Antidiphtheria immunity at children with allergic diseases
by: A V Labushkina, et al.
Published: (2009-12-01)

Pharmacokinetic properties of the preparations of protein origin
by: A. A. Soldatov, et al.
Published: (2018-02-01)

Development of Immune-Chromatographic Monoclonal Test-System for the Detection of <i>Yersinia pseudotuberculosis</i>, Serogroup I
by: N. V. Bogacheva, et al.
Published: (2016-06-01)

Validation of the technique aimed at the determination of FMD antibodies in liquid phase blocking sandwich Elisa
by: N. N. Lugovskaya, et al.
Published: (2018-04-01)

Возможности сочетания иммунотерапии с лучевой терапией в лечении больных неоперабельным местно-распространённым немелкоклеточным раком легкого. Обзор литературы.
Published: (2021-06-01)

Сравнительная эффективность и безопасность применения препаратов моноклональных антител к ИЛ-6 у пациентов с новой коронавирусной инфекцией COVID-19 тяжелого течения. Ретроспективное когортное исследование
by: С. С. Бобкова, et al.
Published: (2021-03-01)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review
by: D. L. Klabukova, et al.
Published: (2018-07-01)

Метод РНК-интерференции в защите растений от насекомых-вредителей
by: Владимир Сергеевич Журавлев, et al.
Published: (2022-04-01)

Validation of the XTT-test for assessing the antiproliferative activity of biologics on the basis of monoclonal antibodies
by: I. V. Lyagoskin, et al.
Published: (2018-02-01)

FREQUENCY OF OCCURRENCE OF ANTIBODIES TO HLA ANTIGENS IN RECIPIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANTATION
by: Елена Борисовна Лукоянычева, et al.
Published: (2023-02-01)

The morphological changes dynamics of ovarian reproductive apparatus in the experimental autoimmune oophoritis
by: M. L. Dmitriyeva, et al.
Published: (2012-02-01)

The Value of the Effect of the Level of Specific Antibodeis on Elimination Different Tick-Borne Encephalitis Virus Strains
by: G. N. Leonova, et al.
Published: (2017-04-01)

Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
by: A. A. Lidzhieva, et al.
Published: (2018-02-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
by: N. T. Tikhonova, et al.
Published: (2017-12-01)

Construction and Investigation of the Variants of the Vaccine Strain <I>Francisella tularensis</I> Lacking <I>iglC </I>Genes. Communication 2
by: A. N. Mokrievich, et al.
Published: (2013-12-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
by: A. V. Vatazin, et al.
Published: (2021-01-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
by: V. G. Dedkov, et al.
Published: (2015-09-01)

Construction and Approval of the Test-System for the Detection of Antibodies to Anthrax Agent Using Indirect Fluorescent Immunoassay
by: L. Yu. Aksenova, et al.
Published: (2013-12-01)

Antikeratin antibodies in rheumatoid arthritis
by: J Zabek
Published: (2003-02-01)

Заболявания, свързани с анти-миелинови олигодендроцитни гликопротеинови антитела (MOG-antibody diseases)
by: Sonia Ivanova, et al.
Published: (2019-09-01)

The possible role of toxoplasmosis in the development of antiphospholipid antibodies in pregnancy-related complications
by: - Bayati Ali Hattem Hussein, et al.
Published: (2012-09-01)

Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
by: A. A. Lopatin, et al.
Published: (2015-09-01)

Future Developments and Applications of the Vaccines against Dangerous Viral Infections, RNA-Replicon-Based, Obtained from the Venezuelan Equine Encephalomyelitis Virus
by: A. A. Petrov, et al.
Published: (2014-09-01)